Creative Diagnostics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

creative-diagnostics.com

Founded Year

2005

About Creative Diagnostics

Creative Diagnostics manufactures and markets specialty immunoassays. Fully-automated and semi-automated system options are available that utilize advanced direct label technology to meet the throughput needs of both large and small independent and hospital laboratories. Creative diagnostics offers a wide range of antibodies validated for use in multiplexed assays, ranging from primary antibodies to cytokines, and more.

Creative Diagnostics Headquarter Location

45-1 Ramsey Road

Shirley, New York, 11967,

United States

631-624-4882

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Creative Diagnostics News

Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies

Apr 13, 2022

Creative Diagnostics Introduces New Nipah Virus Antigens and Antibodies As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a series of  NiV recombinant antigen and antibody  pairs. All of these new products are produced using standardized production processes to ensure the highest quality. Tests developed using these reagents can assist researchers in routine diagnostics and NiV vaccine development. Nipah virus (NiV) was initially isolated and identified in 1999 during an outbreak of encephalitis and respiratory disease among pig farmers and close contacts of pigs in Malaysia and Singapore. It belongs to the newly created genus Henipavirus and is closely related to Hendra virus and Cedar virus. The Henipavirus family is pleomorphic, which means they come in a variety of shapes, typically 40 to 600 nm in diameter. The core of the virion contains a linear ribonucleoprotein (RNP) composed of negative-sense single-stranded RNA. NiV is a highly pathogenic zoonotic virus carried by fruit bats (mainly Pteropus spp) and transmitted from bats to humans. Severe encephalitis and respiratory illnesses caused by NiV infection have occurred almost annually in Bangladesh and India since 2001. However, there are currently no licensed treatments and vaccines for NiV infection in humans. NiV has two membrane-anchored glycoproteins involved in virion cell attachment and subsequent host cell entry, the attachment protein (G) and the fusion protein (F), which are ideal targets for neutralizing antibodies. Various immunization strategies have been developed to prevent NiV infection by utilizing G and/or F glycoprotein antigens, including viral vectors, subunit vaccines, virus-like particles (VLPs) and mRNA vaccines. NiV causes acute encephalitis and high mortality (40-75%). Therefore, effective NiV vaccines and therapeutics are urgently needed. Laboratory detection of NiV can be performed using real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Creative Diagnostics now expands its portfolio and releases a series of NiV recombinant antigen and antibody pairs for research use. Antibodies products such as Anti-Nipah Virus G Protein monoclonal antibody (DMAB-A002), and Magic™ Anti-NIV gF Monoclonal antibody (CABT-RM237) are all available for sandwich ELISA. Recombinant Nipah Virus G Protein (DAGA-1004) and Recombinant Nipah Virus F Protein [His] (DAG-WT633) are also ready for research applications. “Our NiV antigens are post-translationally modified and more closely resembling the native viral proteins, and these monoclonal antibodies can be used as a pair in sandwich ELISA with the rec. protein or in capture IgM assays. Our products are specific to NiV, no cross reaction with Dengue, Zika and Chikungunya envelope proteins.” said Dr. Jessica Waldorf, chief scientific officer of R&D department of Creative Diagnostics. If you want to know more details about NiV antigen and antibody products list or have any other questions about our research materials, please visit Creative Diagnostics at  https://www.creative-diagnostics.com . About Creative Diagnostics Creative Diagnostics is a leading manufacturer and supplier of  antibodies , viral antigens, innovative diagnostic components and critical assay reagents. It also provides contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. It aims to provide a trusted source for all researchers’ assay development and manufacturing needs. Editor Details

Creative Diagnostics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Creative Diagnostics Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.